Altasciences Featured Articles

  1. Historical Background Data In Juvenile Cynomolgus Monkeys 1/27/2025

    This study underscores the importance of exploring underutilized NHP origins to address the limited availability of juvenile NHPs for evaluating advanced therapeutic products.

  2. Development Of A Novel Early Intervention Stabilization For Abdominal Aortic Aneurysms 1/27/2025

    This study highlights the potential of a proprietary catheter combined with a stabilizing agent to provide a much-needed treatment option for abdominal aortic aneurysms.

  3. Development Of A Canine Prostatectomy Model 1/27/2025

    This canine partial prostatectomy model offers an approach for evaluating new prostate cancer therapeutics, providing a reliable system that mimics human procedures while minimizing complications.

  4. Cross-Comparison Of Immunophenotyping Assay Performance In Nonhuman Primates 1/27/2025

    Due to supply constraints of Cambodian NHPs, exploring alternative sources like Philippine and Mauritius-sourced cynomolgus macaques is crucial for maintaining nonclinical safety assessments.

  5. Cross-Comparison Of Biomarker Assay Performance In Nonhuman Primates 1/27/2025

    This presentation compares standard panels, such as cytokines and complements, that are typically evaluated in toxicological studies to determine the viability of these alternative strains.

  6. Clinical Pathology Reference Data For The Philippine Cynomolgus Monkey For Preclinical Toxicology Studies 1/27/2025

    As demand for cynomolgus macaques grows, comprehensive reference data for underutilized origins like Philippine-origin CM is essential for accurate data interpretation in preclinical toxicology programs.

  7. The Sinclair Nanopig™—The Other Non-Rodent 1/27/2025

    Given its close physiological similarities to humans, the minipig should be considered a valuable alternative for nonclinical safety assessments in small molecule and biologic drug development.

  8. Assessing The Safety Of Novel Therapeutics For Pediatric Indications 1/9/2025

    Discover strategies to overcome the challenges of nonclinical testing for pediatric and rare disease therapies, ensuring regulatory compliance and successfully advancing your medicinal products to the clinic.

  9. Safety Assessment Of Intravitreal Implants In Dutch Belted Rabbits 1/9/2025

    Address unique anatomical challenges to deliver reliable, IND-enabling data for innovative therapies by relying on our expertise to design and execute your complex ocular safety study.

  10. Nanosuspension Formulation To Maximize Potency For Preclinical Studies 1/9/2025

    By having a tailored proactive drug development approach, companies can accelerate their API's journey through preclinical development, ensuring the creation of a stable, high-potency formulation.